Abstract
Cyclosporin O (CyO), an immunosuppressent cyclic undecapeptide, was synthesized by convergent approach employing Bsmoc-Nmethyl amino acid fluorides and Potassium Salt of 7-Aza-1-hydroxybenzotriazole (KOAt) in solution by stepwise assembly. The couplings were found to be epimerisation free. The difficulty in the coupling of four consecutive N-methyl amino acids at position 8, 9, 10 and 11 was overcome by repeating the coupling thrice at these critical positions. All the ten protected peptide fragments of CyO starting from the dipeptide to the undecapeptide and final protected as well as CyO were isolated and fully characterized.
Keywords: Cyclosporin O, Acid fluoride, KOAt, N-Methyl amino acid, Diethyl amine
Protein & Peptide Letters
Title: Total Synthesis of Cyclosporin O: Exploring the Utility of Bsmoc-NMe- Amino Acid Fluorides and KOAt
Volume: 16 Issue: 3
Author(s): Vommina Venkata Sureshbabu, Subramanyam J. Tantry, Gundala Chennakrishnareddy and Govindappa Nagendra
Affiliation:
Keywords: Cyclosporin O, Acid fluoride, KOAt, N-Methyl amino acid, Diethyl amine
Abstract: Cyclosporin O (CyO), an immunosuppressent cyclic undecapeptide, was synthesized by convergent approach employing Bsmoc-Nmethyl amino acid fluorides and Potassium Salt of 7-Aza-1-hydroxybenzotriazole (KOAt) in solution by stepwise assembly. The couplings were found to be epimerisation free. The difficulty in the coupling of four consecutive N-methyl amino acids at position 8, 9, 10 and 11 was overcome by repeating the coupling thrice at these critical positions. All the ten protected peptide fragments of CyO starting from the dipeptide to the undecapeptide and final protected as well as CyO were isolated and fully characterized.
Export Options
About this article
Cite this article as:
Sureshbabu Venkata Vommina, Tantry J. Subramanyam, Chennakrishnareddy Gundala and Nagendra Govindappa, Total Synthesis of Cyclosporin O: Exploring the Utility of Bsmoc-NMe- Amino Acid Fluorides and KOAt, Protein & Peptide Letters 2009; 16 (3) . https://dx.doi.org/10.2174/092986609787601813
DOI https://dx.doi.org/10.2174/092986609787601813 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Risks of Self-Medication Practices
Current Drug Safety Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
Current Medicinal Chemistry Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19
Current Medicinal Chemistry Structure-Affinity-Relationship Study of Bicyclic σ Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry Synthesis and In Vitro Biological Activity Evaluation of the Derivatives of Combretastatin A-4
Letters in Drug Design & Discovery Molecular Modeling of Human Hepatocyte PKA (cAMP-Dependent Protein Kinase Type-II) and Its Structure Analysis
Protein & Peptide Letters Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimers Disease
Current Medicinal Chemistry The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
Current Medicinal Chemistry Latest in COVID-19 Vaccine 'Candidates' Race
Infectious Disorders - Drug Targets Recent Updates on the Anticancer Activity of Quinoxaline Hybrids (Jan. 2017-Jan. 2022)
Current Topics in Medicinal Chemistry Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon
Current Pharmaceutical Biotechnology Recent Advances in NNRTI Design: Computer-Aided Molecular Design Approaches
Current Computer-Aided Drug Design Non-Covalent Cathepsin K Inhibitors for the Treatment of Osteoporosis
Current Topics in Medicinal Chemistry COVID-19: Pathogenesis and Pharmacological Basis for Use of Passive Antibody Therapy
Current Drug Therapy Structural Alerts of Mutagens and Carcinogens
Current Computer-Aided Drug Design A Review of Natural Products with Anti-Biofilm Activity
Current Organic Chemistry [General Articles] Aurones: A Subclass of Flavones with Promising Biological Potential
Current Medicinal Chemistry The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Current Cancer Drug Targets Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening
Current Pharmaceutical Biotechnology